Melanoma Clinical Trials in San Diego

Showing 61-80 of 174 trials

Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors

NCT05909995

The purpose of this study is to characterize the safety, tolerability, PK, and efficacy of INCB 99280 in combination with ipilimumab in participants with select solid tumors.

MelanomaHepatocellular Carcinoma (HCC)Renal Cell Carcinoma (RCC)+3 more

Incyte Corporation8 participantsStarted Aug 2023

Los Angeles, California, United States • Orange, California, United States • San Diego, California, United States +5 more locations

TERMINATEDPhase 111 miles

Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors

NCT03991741

To determine whether special tumor fighting cells that is taken from participants' tumors and grown in the laboratory and then given back to the participant will fight the participant's cancer when their immune system is suppressed from attacking these special tumor fighting cells.

Metastatic MelanomaLocally Advanced Refractory/Recurrent MelanomaMetastatic Head and Neck Cancer+1 more

Gregory Daniels3 participantsStarted Oct 2020

La Jolla, California, United States

TERMINATEDPhase 211 miles

Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6

NCT04830124

This study observes the antitumor activity, safety, tolerability, PK, and pharmacodynamics in patients with inoperable and/or metastatic melanoma

Cutaneous MelanomaMucosal Melanoma

Mural Oncology, Inc173 participantsStarted Sep 2021

La Jolla, California, United States • Los Angeles, California, United States • Jacksonville, Florida, United States +38 more locations

Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors

Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors

Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6

Melanoma Trials in Other Cities

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma

High Dose IL-2 in Combination With Anti-PD-1 to Overcome Anti-PD-1 Resistance in Metastatic Melanoma and Renal Cell Carcinoma

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

A Study of SEA-CD40 Given With Other Drugs in Cancers

A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07).

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Milademetan in Advanced/Metastatic Solid Tumors

Other Conditions in San Diego